3,4-Ethylenedioxyamphetamine

3,4-Ethylenedioxyamphetamine, also known as EDA-6, is a drug of the phenethylamine, amphetamine, and EDxx families related to 3,4-methylenedioxyamphetamine. It is closely related to analogues including 3,4-ethylenedioxymethamphetamine, 3,4-ethylidenedioxyamphetamine, and 3,4-isopropylidenedioxyamphetamine. EDMA, the N-methylated analogue of EDA, is known to be a serotonin–norepinephrine–dopamine releasing agent. According to Alexander Shulgin however, the drug only produced limited psychoactive effects in humans at doses in the range of 150 to 250mg.